TAGRISSO Co-pay Savings Program (AZ Access 360)
AstraZeneca · Tagrisso
Patient pays: as little as $0 per month
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Tagrisso assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Tagrisso help that still works on Medicare or Medicaid - the programs copay cards leave out.
Tagrisso (osimertinib) is an egfr tyrosine kinase inhibitor (oral oncology) made by AstraZeneca. It is commonly prescribed for: EGFR-positive non-small cell lung cancer (advanced and adjuvant), EGFR T790M-positive metastatic NSCLC. Without financial assistance, Tagrisso typically costs around $19,000 per month.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
AstraZeneca · Tagrisso
Patient pays: as little as $0 per month
commercial insurance
AstraZeneca · Tagrisso
uninsured · Medicare Part D
Common questions
Related drugs